Medicine and Dentistry
Androgen Deprivation Therapy
5%
Biochemical Recurrence
19%
Biochemical Recurrence Free Survival
8%
Biological Marker
5%
Biopsy Technique
37%
Bladder
30%
Bladder Cancer
24%
Bladder Outlet Obstruction
11%
Bladder Tumor
8%
Bleeding
9%
Body Mass Index
13%
Cancer Cell
5%
Cancer Specific Survival
19%
Chronic Kidney Disease
6%
Clear Cell Renal Cell Carcinoma
56%
Cohort Analysis
5%
Computer Assisted Tomography
6%
Continence
9%
Cystectomy
25%
Detrusor
12%
Diabetes Mellitus
6%
Enucleation
17%
Enuresis
9%
Erectile Dysfunction
12%
Gleason Score
27%
Glomerular Filtration Rate
8%
Hazard Ratio
19%
Holmium
16%
Hydronephrosis
5%
Incontinence
7%
International Index of Erectile Function
5%
International Prostate Symptom Score
22%
Kidney Function
16%
Kidney Metastasis
11%
Kidney Stone
18%
Kidney Tumour
12%
Laparoendoscopic Single Site Surgery
7%
Laparoscopic Surgery
5%
Logistic Regression Analysis
6%
Lower Urinary Tract Symptom
28%
Lymph Node
7%
Lymphocyte
7%
Lymphovascular Invasion
6%
Magnetic Resonance Imaging
13%
Meta-Analysis
10%
Metastatic Carcinoma
8%
Micturition
5%
Neoplasm
40%
Nephrectomy
13%
Nephroureterectomy
14%
Neurogenic Bladder
5%
Neutrophil
6%
Nocturia
7%
Non Muscle Invasive Bladder Cancer
6%
Odds Ratio
16%
Overactive Bladder
17%
Overall Survival
21%
Partial Nephrectomy
22%
Pelvis
9%
Percutaneous Nephrolithotomy
5%
Postoperative Complication
5%
Predictive Factor
9%
Prevalence
12%
Prognostic Factor
19%
Programmed Cell Death
6%
Progression Free Survival
7%
Propensity Score Matching
5%
Proportional Hazards Model
12%
Prospective Study
9%
Prostate Biopsy
19%
Prostate Cancer
100%
Prostate Hypertrophy
29%
Prostate Specific Antigen
38%
Prostatectomy
57%
Radical Nephrectomy
18%
Radical Retropubic Prostatectomy
10%
Randomized Controlled Trial
5%
Recurrence Free Survival
11%
Recurrent Disease
20%
Retrospective Study
5%
Robot-Assisted Prostatectomy
11%
Smooth Muscle
5%
Spinal Cord Injury
6%
Stress Incontinence
7%
Surgical Margin
11%
Survival Rate
12%
Transitional Cell Carcinoma
38%
Transrectal Ultrasonography
15%
Transurethral Resection
10%
Upper Urinary Tract
15%
Ureter
10%
Urinary System
12%
Urodynamics
19%
Uroflowmetry
5%
Urothelial Cancer
5%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
5%
Biochemical Recurrence
8%
Biochemical Recurrence Free Survival
5%
Bladder Cancer
19%
Bladder Obstruction
6%
Cancer Specific Survival
5%
Castration Resistant Prostate Cancer
8%
Cisplatin
7%
Diabetes Mellitus
5%
Erectile Dysfunction
11%
Gleason Score
12%
Kidney Metastasis
6%
Kidney Stone
8%
Lower Urinary Tract Symptom
17%
Neoplasm
18%
Non Muscle Invasive Bladder Cancer
5%
Overactive Bladder
9%
Overall Survival
12%
Placebo
6%
Prevalence
6%
Progression Free Survival
6%
Prostate Cancer
46%
Prostate Hypertrophy
15%
Prostate Specific Antigen
17%
Rat Model
5%
Recurrent Disease
10%
Renal Cell Carcinoma
14%
Transitional Cell Carcinoma
13%